Click for best price
Antigen AntibodY for Diagnostic Market Size, Share 2024
| Market size in 2023 |
US$ 8460.4 million
|
Forecast Market size by 2030 |
US$ 14640 million
|
| Growth Rate |
CAGR of 8.2% |
Number of Pages |
119 Pages |
The global Antigen and AntibodY for Diagnostic market was valued at US$ 8460.4 million in 2023 and is projected to reach US$ 14640 million by 2030, at a CAGR of 8.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Antigens and Antibodies for Diagnostic is materials used to prepare in vitro diagnostic (IVD) reagent products. Antibodies are the raw materials for the preparation of antibody-based in vitro diagnostic reagents, including monoclonal antibodies and polyclonal antibodies. Antibodies are prepared by methods such as immunization technology, hybridoma cell technology, and cell fermentation technology, and are used in the diagnosis of cardiovascular diseases, tumors, and infectious diseases.In terms of product type, type chemiluminescence is the largest segment, occupied for a share of 52.29%, and in terms of application, application thyroid function has a share about 24.03 percent.Global top five manufacturers of Antigens and Antibodies for Diagnostic occupied for a share nearly 12.5 percent, key players are Roche, Fapon Biotech Inc, Sino Biological Inc, HyTest Ltd (Mindray), and Meridian Bioscience, etc.
This report aims to provide a comprehensive presentation of the global market for Antigen and AntibodY for Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antigen and AntibodY for Diagnostic. This report contains market size and forecasts of Antigen and AntibodY for Diagnostic in global, including the following market information:
Global Antigen and AntibodY for Diagnostic Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Antigen and AntibodY for Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antigen and AntibodY for Diagnostic Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Antigen and AntibodY for Diagnostic Market Segment Percentages, by Type, 2023 (%)
Enzyme-linked Immunoassay
Chemiluminescence
Colloidal Gold
Immunoturbidimetric Method
Global Antigen and AntibodY for Diagnostic Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Antigen and AntibodY for Diagnostic Market Segment Percentages, by Application, 2023 (%)
Tumours
Thyroid Function
Kidney Function
Infectious Diseases
Cardiovascular and Cardiac Markers
Stimulant
Global Antigen and AntibodY for Diagnostic Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Antigen and AntibodY for Diagnostic Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antigen and AntibodY for Diagnostic revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Antigen and AntibodY for Diagnostic revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Fapon Biotech Inc
Sino Biological Inc
HyTest Ltd (Mindray)
Meridian Bioscience
BBI Solutions
Autobio
Thermo Fisher
GenScript Biotech Corporation
Medix Biochemica
ACROBiosystems Group
Bio-Techne
Merck KGaA
Novoprotein Scientific Inc
Abclonal
Creative Diagnostics
BD
Cell Signaling Technology (CST)
Vazyme
Genstars Biotech Co
Asahi Biotech (Hangzhou Anxu Biotechnology)
Abcepta
Agilent Technologies
Beijing APIS Bioscience Co
CUSABIO
One Clone
Immunology Consultants Laboratory
Artron BioResearch Inc
Cwbio IT Group
BIOGENOME
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antigen and AntibodY for Diagnostic, market overview.
Chapter 2: Global Antigen and AntibodY for Diagnostic market size in revenue.
Chapter 3: Detailed analysis of Antigen and AntibodY for Diagnostic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antigen and AntibodY for Diagnostic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Antigen and AntibodY for Diagnostic Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 8460.4 million
|
| Forecast Market size by 2030 |
US$ 14640 million
|
| Growth Rate |
CAGR of 8.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
119 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antigen and AntibodY for Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antigen and AntibodY for Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antigen and AntibodY for Diagnostic Overall Market Size
2.1 Global Antigen and AntibodY for Diagnostic Market Size: 2023 VS 2030
2.2 Global Antigen and AntibodY for Diagnostic Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antigen and AntibodY for Diagnostic Players in Global Market
3.2 Top Global Antigen and AntibodY for Diagnostic Companies Ranked by Revenue
3.3 Global Antigen and AntibodY for Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Antigen and AntibodY for Diagnostic Companies in Global Market, by Revenue in 2023
3.5 Global Companies Antigen and AntibodY for Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antigen and AntibodY for Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 Antigen and AntibodY for Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 Antigen and AntibodY for Diagnostic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Antigen and AntibodY for Diagnostic Market Size Markets, 2023 & 2030
4.1.2 Enzyme-linked Immunoassay
4.1.3 Chemiluminescence
4.1.4 Colloidal Gold
4.1.5 Immunoturbidimetric Method
4.2 By Type - Global Antigen and AntibodY for Diagnostic Revenue & Forecasts
4.2.1 By Type - Global Antigen and AntibodY for Diagnostic Revenue, 2019-2024
4.2.2 By Type - Global Antigen and AntibodY for Diagnostic Revenue, 2025-2030
4.2.3 By Type - Global Antigen and AntibodY for Diagnostic Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antigen and AntibodY for Diagnostic Market Size, 2023 & 2030
5.1.2 Tumours
5.1.3 Thyroid Function
5.1.4 Kidney Function
5.1.5 Infectious Diseases
5.1.6 Cardiovascular and Cardiac Markers
5.1.7 Stimulant
5.2 By Application - Global Antigen and AntibodY for Diagnostic Revenue & Forecasts
5.2.1 By Application - Global Antigen and AntibodY for Diagnostic Revenue, 2019-2024
5.2.2 By Application - Global Antigen and AntibodY for Diagnostic Revenue, 2025-2030
5.2.3 By Application - Global Antigen and AntibodY for Diagnostic Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Antigen and AntibodY for Diagnostic Market Size, 2023 & 2030
6.2 By Region - Global Antigen and AntibodY for Diagnostic Revenue & Forecasts
6.2.1 By Region - Global Antigen and AntibodY for Diagnostic Revenue, 2019-2024
6.2.2 By Region - Global Antigen and AntibodY for Diagnostic Revenue, 2025-2030
6.2.3 By Region - Global Antigen and AntibodY for Diagnostic Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Antigen and AntibodY for Diagnostic Revenue, 2019-2030
6.3.2 US Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.3.3 Canada Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.3.4 Mexico Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Antigen and AntibodY for Diagnostic Revenue, 2019-2030
6.4.2 Germany Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.4.3 France Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.4.4 U.K. Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.4.5 Italy Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.4.6 Russia Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.4.7 Nordic Countries Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.4.8 Benelux Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Antigen and AntibodY for Diagnostic Revenue, 2019-2030
6.5.2 China Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.5.3 Japan Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.5.4 South Korea Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.5.5 Southeast Asia Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.5.6 India Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Antigen and AntibodY for Diagnostic Revenue, 2019-2030
6.6.2 Brazil Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.6.3 Argentina Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antigen and AntibodY for Diagnostic Revenue, 2019-2030
6.7.2 Turkey Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.7.3 Israel Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.7.4 Saudi Arabia Antigen and AntibodY for Diagnostic Market Size, 2019-2030
6.7.5 UAE Antigen and AntibodY for Diagnostic Market Size, 2019-2030
7 Antigen and AntibodY for Diagnostic Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Antigen and AntibodY for Diagnostic Major Product Offerings
7.1.4 Roche Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.1.5 Roche Key News & Latest Developments
7.2 Fapon Biotech Inc
7.2.1 Fapon Biotech Inc Company Summary
7.2.2 Fapon Biotech Inc Business Overview
7.2.3 Fapon Biotech Inc Antigen and AntibodY for Diagnostic Major Product Offerings
7.2.4 Fapon Biotech Inc Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.2.5 Fapon Biotech Inc Key News & Latest Developments
7.3 Sino Biological Inc
7.3.1 Sino Biological Inc Company Summary
7.3.2 Sino Biological Inc Business Overview
7.3.3 Sino Biological Inc Antigen and AntibodY for Diagnostic Major Product Offerings
7.3.4 Sino Biological Inc Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.3.5 Sino Biological Inc Key News & Latest Developments
7.4 HyTest Ltd (Mindray)
7.4.1 HyTest Ltd (Mindray) Company Summary
7.4.2 HyTest Ltd (Mindray) Business Overview
7.4.3 HyTest Ltd (Mindray) Antigen and AntibodY for Diagnostic Major Product Offerings
7.4.4 HyTest Ltd (Mindray) Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.4.5 HyTest Ltd (Mindray) Key News & Latest Developments
7.5 Meridian Bioscience
7.5.1 Meridian Bioscience Company Summary
7.5.2 Meridian Bioscience Business Overview
7.5.3 Meridian Bioscience Antigen and AntibodY for Diagnostic Major Product Offerings
7.5.4 Meridian Bioscience Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.5.5 Meridian Bioscience Key News & Latest Developments
7.6 BBI Solutions
7.6.1 BBI Solutions Company Summary
7.6.2 BBI Solutions Business Overview
7.6.3 BBI Solutions Antigen and AntibodY for Diagnostic Major Product Offerings
7.6.4 BBI Solutions Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.6.5 BBI Solutions Key News & Latest Developments
7.7 Autobio
7.7.1 Autobio Company Summary
7.7.2 Autobio Business Overview
7.7.3 Autobio Antigen and AntibodY for Diagnostic Major Product Offerings
7.7.4 Autobio Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.7.5 Autobio Key News & Latest Developments
7.8 Thermo Fisher
7.8.1 Thermo Fisher Company Summary
7.8.2 Thermo Fisher Business Overview
7.8.3 Thermo Fisher Antigen and AntibodY for Diagnostic Major Product Offerings
7.8.4 Thermo Fisher Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.8.5 Thermo Fisher Key News & Latest Developments
7.9 GenScript Biotech Corporation
7.9.1 GenScript Biotech Corporation Company Summary
7.9.2 GenScript Biotech Corporation Business Overview
7.9.3 GenScript Biotech Corporation Antigen and AntibodY for Diagnostic Major Product Offerings
7.9.4 GenScript Biotech Corporation Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.9.5 GenScript Biotech Corporation Key News & Latest Developments
7.10 Medix Biochemica
7.10.1 Medix Biochemica Company Summary
7.10.2 Medix Biochemica Business Overview
7.10.3 Medix Biochemica Antigen and AntibodY for Diagnostic Major Product Offerings
7.10.4 Medix Biochemica Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.10.5 Medix Biochemica Key News & Latest Developments
7.11 ACROBiosystems Group
7.11.1 ACROBiosystems Group Company Summary
7.11.2 ACROBiosystems Group Business Overview
7.11.3 ACROBiosystems Group Antigen and AntibodY for Diagnostic Major Product Offerings
7.11.4 ACROBiosystems Group Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.11.5 ACROBiosystems Group Key News & Latest Developments
7.12 Bio-Techne
7.12.1 Bio-Techne Company Summary
7.12.2 Bio-Techne Business Overview
7.12.3 Bio-Techne Antigen and AntibodY for Diagnostic Major Product Offerings
7.12.4 Bio-Techne Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.12.5 Bio-Techne Key News & Latest Developments
7.13 Merck KGaA
7.13.1 Merck KGaA Company Summary
7.13.2 Merck KGaA Business Overview
7.13.3 Merck KGaA Antigen and AntibodY for Diagnostic Major Product Offerings
7.13.4 Merck KGaA Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.13.5 Merck KGaA Key News & Latest Developments
7.14 Novoprotein Scientific Inc
7.14.1 Novoprotein Scientific Inc Company Summary
7.14.2 Novoprotein Scientific Inc Business Overview
7.14.3 Novoprotein Scientific Inc Antigen and AntibodY for Diagnostic Major Product Offerings
7.14.4 Novoprotein Scientific Inc Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.14.5 Novoprotein Scientific Inc Key News & Latest Developments
7.15 Abclonal
7.15.1 Abclonal Company Summary
7.15.2 Abclonal Business Overview
7.15.3 Abclonal Antigen and AntibodY for Diagnostic Major Product Offerings
7.15.4 Abclonal Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.15.5 Abclonal Key News & Latest Developments
7.16 Creative Diagnostics
7.16.1 Creative Diagnostics Company Summary
7.16.2 Creative Diagnostics Business Overview
7.16.3 Creative Diagnostics Antigen and AntibodY for Diagnostic Major Product Offerings
7.16.4 Creative Diagnostics Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.16.5 Creative Diagnostics Key News & Latest Developments
7.17 BD
7.17.1 BD Company Summary
7.17.2 BD Business Overview
7.17.3 BD Antigen and AntibodY for Diagnostic Major Product Offerings
7.17.4 BD Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.17.5 BD Key News & Latest Developments
7.18 Cell Signaling Technology (CST)
7.18.1 Cell Signaling Technology (CST) Company Summary
7.18.2 Cell Signaling Technology (CST) Business Overview
7.18.3 Cell Signaling Technology (CST) Antigen and AntibodY for Diagnostic Major Product Offerings
7.18.4 Cell Signaling Technology (CST) Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.18.5 Cell Signaling Technology (CST) Key News & Latest Developments
7.19 Vazyme
7.19.1 Vazyme Company Summary
7.19.2 Vazyme Business Overview
7.19.3 Vazyme Antigen and AntibodY for Diagnostic Major Product Offerings
7.19.4 Vazyme Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.19.5 Vazyme Key News & Latest Developments
7.20 Genstars Biotech Co
7.20.1 Genstars Biotech Co Company Summary
7.20.2 Genstars Biotech Co Business Overview
7.20.3 Genstars Biotech Co Antigen and AntibodY for Diagnostic Major Product Offerings
7.20.4 Genstars Biotech Co Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.20.5 Genstars Biotech Co Key News & Latest Developments
7.21 Asahi Biotech (Hangzhou Anxu Biotechnology)
7.21.1 Asahi Biotech (Hangzhou Anxu Biotechnology) Company Summary
7.21.2 Asahi Biotech (Hangzhou Anxu Biotechnology) Business Overview
7.21.3 Asahi Biotech (Hangzhou Anxu Biotechnology) Antigen and AntibodY for Diagnostic Major Product Offerings
7.21.4 Asahi Biotech (Hangzhou Anxu Biotechnology) Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.21.5 Asahi Biotech (Hangzhou Anxu Biotechnology) Key News & Latest Developments
7.22 Abcepta
7.22.1 Abcepta Company Summary
7.22.2 Abcepta Business Overview
7.22.3 Abcepta Antigen and AntibodY for Diagnostic Major Product Offerings
7.22.4 Abcepta Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.22.5 Abcepta Key News & Latest Developments
7.23 Agilent Technologies
7.23.1 Agilent Technologies Company Summary
7.23.2 Agilent Technologies Business Overview
7.23.3 Agilent Technologies Antigen and AntibodY for Diagnostic Major Product Offerings
7.23.4 Agilent Technologies Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.23.5 Agilent Technologies Key News & Latest Developments
7.24 Beijing APIS Bioscience Co
7.24.1 Beijing APIS Bioscience Co Company Summary
7.24.2 Beijing APIS Bioscience Co Business Overview
7.24.3 Beijing APIS Bioscience Co Antigen and AntibodY for Diagnostic Major Product Offerings
7.24.4 Beijing APIS Bioscience Co Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.24.5 Beijing APIS Bioscience Co Key News & Latest Developments
7.25 CUSABIO
7.25.1 CUSABIO Company Summary
7.25.2 CUSABIO Business Overview
7.25.3 CUSABIO Antigen and AntibodY for Diagnostic Major Product Offerings
7.25.4 CUSABIO Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.25.5 CUSABIO Key News & Latest Developments
7.26 One Clone
7.26.1 One Clone Company Summary
7.26.2 One Clone Business Overview
7.26.3 One Clone Antigen and AntibodY for Diagnostic Major Product Offerings
7.26.4 One Clone Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.26.5 One Clone Key News & Latest Developments
7.27 Immunology Consultants Laboratory
7.27.1 Immunology Consultants Laboratory Company Summary
7.27.2 Immunology Consultants Laboratory Business Overview
7.27.3 Immunology Consultants Laboratory Antigen and AntibodY for Diagnostic Major Product Offerings
7.27.4 Immunology Consultants Laboratory Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.27.5 Immunology Consultants Laboratory Key News & Latest Developments
7.28 Artron BioResearch Inc
7.28.1 Artron BioResearch Inc Company Summary
7.28.2 Artron BioResearch Inc Business Overview
7.28.3 Artron BioResearch Inc Antigen and AntibodY for Diagnostic Major Product Offerings
7.28.4 Artron BioResearch Inc Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.28.5 Artron BioResearch Inc Key News & Latest Developments
7.29 Cwbio IT Group
7.29.1 Cwbio IT Group Company Summary
7.29.2 Cwbio IT Group Business Overview
7.29.3 Cwbio IT Group Antigen and AntibodY for Diagnostic Major Product Offerings
7.29.4 Cwbio IT Group Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.29.5 Cwbio IT Group Key News & Latest Developments
7.30 BIOGENOME
7.30.1 BIOGENOME Company Summary
7.30.2 BIOGENOME Business Overview
7.30.3 BIOGENOME Antigen and AntibodY for Diagnostic Major Product Offerings
7.30.4 BIOGENOME Antigen and AntibodY for Diagnostic Revenue in Global Market (2019-2024)
7.30.5 BIOGENOME Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Antigen and AntibodY for Diagnostic Market Opportunities & Trends in Global Market
Table 2. Antigen and AntibodY for Diagnostic Market Drivers in Global Market
Table 3. Antigen and AntibodY for Diagnostic Market Restraints in Global Market
Table 4. Key Players of Antigen and AntibodY for Diagnostic in Global Market
Table 5. Top Antigen and AntibodY for Diagnostic Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Antigen and AntibodY for Diagnostic Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Antigen and AntibodY for Diagnostic Revenue Share by Companies, 2019-2024
Table 8. Global Companies Antigen and AntibodY for Diagnostic Product Type
Table 9. List of Global Tier 1 Antigen and AntibodY for Diagnostic Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antigen and AntibodY for Diagnostic Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Antigen and AntibodY for Diagnostic Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Antigen and AntibodY for Diagnostic Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Antigen and AntibodY for Diagnostic Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Antigen and AntibodY for Diagnostic Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Antigen and AntibodY for Diagnostic Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Antigen and AntibodY for Diagnostic Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2025-2030
Table 30. Roche Company Summary
Table 31. Roche Antigen and AntibodY for Diagnostic Product Offerings
Table 32. Roche Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 33. Roche Key News & Latest Developments
Table 34. Fapon Biotech Inc Company Summary
Table 35. Fapon Biotech Inc Antigen and AntibodY for Diagnostic Product Offerings
Table 36. Fapon Biotech Inc Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 37. Fapon Biotech Inc Key News & Latest Developments
Table 38. Sino Biological Inc Company Summary
Table 39. Sino Biological Inc Antigen and AntibodY for Diagnostic Product Offerings
Table 40. Sino Biological Inc Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 41. Sino Biological Inc Key News & Latest Developments
Table 42. HyTest Ltd (Mindray) Company Summary
Table 43. HyTest Ltd (Mindray) Antigen and AntibodY for Diagnostic Product Offerings
Table 44. HyTest Ltd (Mindray) Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 45. HyTest Ltd (Mindray) Key News & Latest Developments
Table 46. Meridian Bioscience Company Summary
Table 47. Meridian Bioscience Antigen and AntibodY for Diagnostic Product Offerings
Table 48. Meridian Bioscience Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 49. Meridian Bioscience Key News & Latest Developments
Table 50. BBI Solutions Company Summary
Table 51. BBI Solutions Antigen and AntibodY for Diagnostic Product Offerings
Table 52. BBI Solutions Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 53. BBI Solutions Key News & Latest Developments
Table 54. Autobio Company Summary
Table 55. Autobio Antigen and AntibodY for Diagnostic Product Offerings
Table 56. Autobio Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 57. Autobio Key News & Latest Developments
Table 58. Thermo Fisher Company Summary
Table 59. Thermo Fisher Antigen and AntibodY for Diagnostic Product Offerings
Table 60. Thermo Fisher Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 61. Thermo Fisher Key News & Latest Developments
Table 62. GenScript Biotech Corporation Company Summary
Table 63. GenScript Biotech Corporation Antigen and AntibodY for Diagnostic Product Offerings
Table 64. GenScript Biotech Corporation Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 65. GenScript Biotech Corporation Key News & Latest Developments
Table 66. Medix Biochemica Company Summary
Table 67. Medix Biochemica Antigen and AntibodY for Diagnostic Product Offerings
Table 68. Medix Biochemica Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 69. Medix Biochemica Key News & Latest Developments
Table 70. ACROBiosystems Group Company Summary
Table 71. ACROBiosystems Group Antigen and AntibodY for Diagnostic Product Offerings
Table 72. ACROBiosystems Group Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 73. ACROBiosystems Group Key News & Latest Developments
Table 74. Bio-Techne Company Summary
Table 75. Bio-Techne Antigen and AntibodY for Diagnostic Product Offerings
Table 76. Bio-Techne Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 77. Bio-Techne Key News & Latest Developments
Table 78. Merck KGaA Company Summary
Table 79. Merck KGaA Antigen and AntibodY for Diagnostic Product Offerings
Table 80. Merck KGaA Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 81. Merck KGaA Key News & Latest Developments
Table 82. Novoprotein Scientific Inc Company Summary
Table 83. Novoprotein Scientific Inc Antigen and AntibodY for Diagnostic Product Offerings
Table 84. Novoprotein Scientific Inc Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 85. Novoprotein Scientific Inc Key News & Latest Developments
Table 86. Abclonal Company Summary
Table 87. Abclonal Antigen and AntibodY for Diagnostic Product Offerings
Table 88. Abclonal Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 89. Abclonal Key News & Latest Developments
Table 90. Creative Diagnostics Company Summary
Table 91. Creative Diagnostics Antigen and AntibodY for Diagnostic Product Offerings
Table 92. Creative Diagnostics Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 93. Creative Diagnostics Key News & Latest Developments
Table 94. BD Company Summary
Table 95. BD Antigen and AntibodY for Diagnostic Product Offerings
Table 96. BD Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 97. BD Key News & Latest Developments
Table 98. Cell Signaling Technology (CST) Company Summary
Table 99. Cell Signaling Technology (CST) Antigen and AntibodY for Diagnostic Product Offerings
Table 100. Cell Signaling Technology (CST) Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 101. Cell Signaling Technology (CST) Key News & Latest Developments
Table 102. Vazyme Company Summary
Table 103. Vazyme Antigen and AntibodY for Diagnostic Product Offerings
Table 104. Vazyme Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 105. Vazyme Key News & Latest Developments
Table 106. Genstars Biotech Co Company Summary
Table 107. Genstars Biotech Co Antigen and AntibodY for Diagnostic Product Offerings
Table 108. Genstars Biotech Co Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 109. Genstars Biotech Co Key News & Latest Developments
Table 110. Asahi Biotech (Hangzhou Anxu Biotechnology) Company Summary
Table 111. Asahi Biotech (Hangzhou Anxu Biotechnology) Antigen and AntibodY for Diagnostic Product Offerings
Table 112. Asahi Biotech (Hangzhou Anxu Biotechnology) Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 113. Asahi Biotech (Hangzhou Anxu Biotechnology) Key News & Latest Developments
Table 114. Abcepta Company Summary
Table 115. Abcepta Antigen and AntibodY for Diagnostic Product Offerings
Table 116. Abcepta Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 117. Abcepta Key News & Latest Developments
Table 118. Agilent Technologies Company Summary
Table 119. Agilent Technologies Antigen and AntibodY for Diagnostic Product Offerings
Table 120. Agilent Technologies Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 121. Agilent Technologies Key News & Latest Developments
Table 122. Beijing APIS Bioscience Co Company Summary
Table 123. Beijing APIS Bioscience Co Antigen and AntibodY for Diagnostic Product Offerings
Table 124. Beijing APIS Bioscience Co Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 125. Beijing APIS Bioscience Co Key News & Latest Developments
Table 126. CUSABIO Company Summary
Table 127. CUSABIO Antigen and AntibodY for Diagnostic Product Offerings
Table 128. CUSABIO Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 129. CUSABIO Key News & Latest Developments
Table 130. One Clone Company Summary
Table 131. One Clone Antigen and AntibodY for Diagnostic Product Offerings
Table 132. One Clone Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 133. One Clone Key News & Latest Developments
Table 134. Immunology Consultants Laboratory Company Summary
Table 135. Immunology Consultants Laboratory Antigen and AntibodY for Diagnostic Product Offerings
Table 136. Immunology Consultants Laboratory Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 137. Immunology Consultants Laboratory Key News & Latest Developments
Table 138. Artron BioResearch Inc Company Summary
Table 139. Artron BioResearch Inc Antigen and AntibodY for Diagnostic Product Offerings
Table 140. Artron BioResearch Inc Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 141. Artron BioResearch Inc Key News & Latest Developments
Table 142. Cwbio IT Group Company Summary
Table 143. Cwbio IT Group Antigen and AntibodY for Diagnostic Product Offerings
Table 144. Cwbio IT Group Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 145. Cwbio IT Group Key News & Latest Developments
Table 146. BIOGENOME Company Summary
Table 147. BIOGENOME Antigen and AntibodY for Diagnostic Product Offerings
Table 148. BIOGENOME Antigen and AntibodY for Diagnostic Revenue (US$, Mn) & (2019-2024)
Table 149. BIOGENOME Key News & Latest Developments
List of Figures
Figure 1. Antigen and AntibodY for Diagnostic Segment by Type in 2023
Figure 2. Antigen and AntibodY for Diagnostic Segment by Application in 2023
Figure 3. Global Antigen and AntibodY for Diagnostic Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Antigen and AntibodY for Diagnostic Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Antigen and AntibodY for Diagnostic Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antigen and AntibodY for Diagnostic Revenue in 2023
Figure 8. By Type - Global Antigen and AntibodY for Diagnostic Revenue Market Share, 2019-2030
Figure 9. By Application - Global Antigen and AntibodY for Diagnostic Revenue Market Share, 2019-2030
Figure 10. By Type - Global Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Antigen and AntibodY for Diagnostic Revenue Market Share, 2019-2030
Figure 12. By Application - Global Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Antigen and AntibodY for Diagnostic Revenue Market Share, 2019-2030
Figure 14. By Region - Global Antigen and AntibodY for Diagnostic Revenue Market Share, 2019-2030
Figure 15. By Country - North America Antigen and AntibodY for Diagnostic Revenue Market Share, 2019-2030
Figure 16. US Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Antigen and AntibodY for Diagnostic Revenue Market Share, 2019-2030
Figure 20. Germany Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 21. France Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Antigen and AntibodY for Diagnostic Revenue Market Share, 2019-2030
Figure 28. China Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 32. India Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Antigen and AntibodY for Diagnostic Revenue Market Share, 2019-2030
Figure 34. Brazil Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Antigen and AntibodY for Diagnostic Revenue Market Share, 2019-2030
Figure 37. Turkey Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Antigen and AntibodY for Diagnostic Revenue, (US$, Mn), 2019-2030
Figure 41. Roche Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Fapon Biotech Inc Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Sino Biological Inc Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. HyTest Ltd (Mindray) Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Meridian Bioscience Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. BBI Solutions Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Autobio Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Thermo Fisher Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. GenScript Biotech Corporation Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Medix Biochemica Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. ACROBiosystems Group Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Bio-Techne Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Merck KGaA Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Novoprotein Scientific Inc Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Abclonal Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. Creative Diagnostics Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. BD Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 58. Cell Signaling Technology (CST) Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 59. Vazyme Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 60. Genstars Biotech Co Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 61. Asahi Biotech (Hangzhou Anxu Biotechnology) Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 62. Abcepta Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 63. Agilent Technologies Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 64. Beijing APIS Bioscience Co Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 65. CUSABIO Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 66. One Clone Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 67. Immunology Consultants Laboratory Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 68. Artron BioResearch Inc Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 69. Cwbio IT Group Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 70. BIOGENOME Antigen and AntibodY for Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
